ITL News & Events

MyHealthTest Achieves Major Milestone of Laboratory Accreditation

MyHealthTest (MHT), a division of ITL Health Group (ASX:ITD) that creates and markets highly innovative direct to consumer pathology testing for major chronic diseases, is very pleased to announce it has been granted accreditation for its testing laboratory to the ISO15189 and NPAAC (National Pathology Accreditation Advisory Council) standards by the National Association of Testing Authorities (NATA) and the Royal College of Pathologists of Australasia (RCPA).

Read More “MyHealthTest Achieves Major Milestone of Laboratory Accreditation” »

Boardroom Media Interview: Strong Half Year Results and ITL BioMedical Update

ITL Limited is pleased to provide the opportunity to listen to an audio interview with Mr Bill Mobbs, Executive Chairman.

Mr Mobbs talks about the Company’s strong first half results that saw revenue rise 11%, EBITDA up 69% and profit before tax grow 110% versus the previous comparative period, and provides an insight into ITL’s innovative products range and the exciting growth opportunities in the BioMedical division.

Read More “Boardroom Media Interview: Strong Half Year Results and ITL BioMedical Update” »

1 2